XRAY
DENTSPLY SIRONA Inc. · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers):
holder breadth +6.2% ·
share flow +19.0% ·
net new positions +5.9%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +3 | 126.41M | $1.34B | +9 | −6 |
| Q1 2026 | 113 | -4 | 123.81M | $1.43B | +7 | −12 |
| Q4 2025 | 118 | -2 | 133.13M | $1.52B | +1 | −2 |
| Q3 2025 | 21 | +1 | 79.76M | $1.01B | +2 | −2 |
| Q2 2025 | 18 | -2 | 86.79M | $1.38B | +1 | −3 |
| Q1 2025 | 17 | +1 | 42.87M | $640.10M | +3 | −2 |
| Q4 2024 | 16 | +2 | 36.02M | $684.31M | +2 | — |
| Q3 2024 | 13 | -1 | 22.34M | $604.46M | — | −1 |
| Q2 2024 | 14 | — | 20.51M | $510.86M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 13.96M | +11.3% | $208.59M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 13.96M | +11.3% | $208.59M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passive) | 6.73M | -0.5% | $101.60M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | AQR Capital Management ✦ | 6.35M | +119.4% | $93.42M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 6.35M | +119.4% | $93.42M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 6.35M | +119.4% | $93.42M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 6.35M | +119.4% | $93.42M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 6.35M | +119.4% | $93.42M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passive) | 3.72M | +3.0% | $55.58M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passive) | 3.72M | +3.0% | $55.58M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Millennium Management ✦ | 3.10M | +60.7% | $46.33M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Norges Bank ✦ (passive) | 2.85M | +18.4% | $42.61M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 1.41M | -16.2% | $21.11M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 1.41M | -16.2% | $21.11M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 1.35M | +34.9% | $20.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 1.35M | +34.9% | $20.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 894.90K | +22.3% | $13.37M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Glenview Capital ✦ | 855.34K | New | $12.78M | 0.3% | New | 1 | SEC ↗ |
| 19 | Marshall Wace ✦ | 810.22K | -2.4% | $12.10M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Marshall Wace ✦ | 810.22K | -2.4% | $12.10M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Marshall Wace ✦ | 810.22K | -2.4% | $12.10M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | Gotham Asset Management ✦ | 272.90K | -64.6% | $4.08M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | Renaissance Technologies ✦ | 249.22K | -35.0% | $3.72M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | ARK Investment Management ✦ | 160.77K | +17.1% | $2.40M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 25 | GAMCO Investors ✦ | 116.79K | +21.5% | $1.74M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 26 | Two Sigma Investments ✦ | 23.93K | New | $357,574 | 0.0% | New | 1 | SEC ↗ |
| 27 | Wellington Management ✦ | 12.71K | New | $189,887 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Glenview Capital | $12.78M | 0.3% |
| Two Sigma Investments | $357,574 | 0.0% |
| Wellington Management | $189,887 | 0.0% |
Exited
| Bridgewater Associates | $4.28M | was 0.0% |
| Point72 Asset Management | $178,971 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 378 holders, 212.22M shares, $2.44B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.